#InnovationsInOncology

[market-insider]

AI-Enhanced Cancer Diagnostics: Market Expansion and Key Players

The global AI in cancer diagnostics market size is expected to reach USD 996.1 million by 2030. The increasing need for lowering healthcare costs, the rising importance of big data in healthcare, improving adoption of precision medicine, and declining hardware costs are key factors driving the growth.

Gain deeper insights on the market and receive your free copy with TOC now @: Artificial Intelligence In Cancer Diagnostics Market Report

The increasing scope of applications of artificial intelligence (AI) in various healthcare fields, including diagnostics; the rising prevalence of cancer; and the growing shortage of public health workforce are some of the key factors anticipated to fuel the adoption of artificial intelligence (AI) in cancer diagnostics over the forecast period. In addition, the increasing applicability of AI-based tools in cancer care and the rise in venture capital investments is further driving the surge in demand for this technology.

The presence of prominent players in the market such as Microsoft, Flatiron, Therapixel, and Tempus, is anticipated to positively impact the growth. These players are adopting strategies such as acquisitions, collaborations, expansions, and new product launches to increase the reach of their products in the industry and increase the availability of their products & services in diverse geographical areas. For instance, in December 2021, Microsoft announced a partnership with CVS Health to develop innovative solutions for patients to improve their health while empowering healthcare professionals with tools to better service patients.

#AICancerDiagnostics #AIinOncology #CancerScreening #EarlyDetection #MedicalAI #OncologyInnovation #CancerResearch #HealthTech #DiagnosticAI #MedicalImaging #AIHealthcare #CancerCare #DataDrivenHealthcare #OncologyTech #HealthcareInnovation #AIResearch #MachineLearningHealthcare #DigitalPathology #InnovationsInOncology

[felixburdastiftung-blog]

Aus der aktuellen Sonderbeilage der @Ärztezeitung zum #Symposium #InnovationsinOncology #onkologie #darmkrebs #krebs #coloncancer #cancer #berlin #ärzte #politik @jensspahn

#berlin #innovationsinoncology #darmkrebs #krebs #ärzte #coloncancer #onkologie #symposium #cancer #politik

[felixburdastiftung-blog]

Super ✅ lief's am vergangenen Freitag in Berlin, beim Symposium #InnovationsinOncology, das vom #NetzwerkgegenDarmkrebs Deutsches @dkfz #NCT #UniversitätsKlinikumHeidelberg #DKG @bild und @Charite veranstaltet wurde. Danke an das Orga-Team Kathrin Schmid-Bodynek (Netzwerk gegen Darmkrebs e.V.), Viktoria Reinhardt (NCT Heidelberg) und Johanna Jacobi (Felix Burda Stiftung) und dickes Lob 🤗👏von Carsten Frederik Buchert (Felix Burda Stiftung).

#dkg #innovationsinoncology #netzwerkgegendarmkrebs #nct #universitätsklinikumheidelberg

[felixburdastiftung-blog]

Ewelina Türk von @adahealth beim Symposium #innovationsinoncology #prävention #bigdata #medizinapp #digitalhealth #ehealth (hier: Radisson Blu Hotel, Berlin)

#medizinapp #digitalhealth #bigdata #prävention #innovationsinoncology #ehealth

[felixburdastiftung-blog]

Prof. Diana Lüftner eröffnet das Symposium #InnovationsinOncology von #DKFZ #NCT #chariteberlin #NetzwerkgegenDarmkrebs #krebs #cancer (hier: Radisson Blu Hotel, Berlin)

#chariteberlin #netzwerkgegendarmkrebs #krebs #cancer #nct #dkfz #innovationsinoncology